Craig A. Johnson

CIK: 0001370348

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AUPH

Aurinia Pharmaceuticals Inc.

Director

HRTX

HERON THERAPEUTICS, INC. /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AUPH
Aurinia Pharmaceuticals Inc.
Jun 4, 2026
Award(A)
Director Stock Option (right to buy)
Direct
23.9K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Direct
54K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Nov 21, 2025
Tax Payment(F)
Direct
6K shares at avg. $15.68$95K
AUPH
Aurinia Pharmaceuticals Inc.
May 16, 2025
Award(A)
Director Stock Option (right to buy)
Direct
37.5K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 31, 2025
Award(A)
Direct
18K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2025
Award(A)
Direct
18K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Nov 21, 2024
Award(A)
Direct
20.6K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	23,931	-	-	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A)	53,960	-	$0	Direct
Nov 21, 2025	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	6,039	$15.68	$94,692	Direct
May 16, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	37,485	-	-	Direct
Jan 31, 2025	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A)	17,950	-	-	Direct
Jan 30, 2025	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A)	17,950	-	-	Direct
Nov 21, 2024	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	20,631	-	$0	Direct

1-7 of 7 transactions

About Johnson Craig A

Johnson Craig A (SEC CIK 0001370348) files insider reports with the SEC as Director of Aurinia Pharmaceuticals Inc. (AUPH) and Director of HERON THERAPEUTICS, INC. /DE/ (HRTX).

Signal8 holds 8 ownership filings by Johnson Craig A (1 Form 3, 7 Form 4), filed between Nov 12, 2024 and Jun 8, 2026. Those filings report 7 transactions, from Nov 21, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Johnson Craig A's filings is in EDMONTON.

Recent filings by Johnson Craig A

Jun 4, 2026: Grant or award of AUPH derivative securities (Form 4, code A).
Jan 30, 2026: Grant or award of HRTX shares (Form 4, code A).
Nov 21, 2025: Tax withholding of AUPH shares (Form 4, code F).
May 16, 2025: Grant or award of AUPH derivative securities (Form 4, code A).
Jan 31, 2025: Grant or award of HRTX shares (Form 4, code A).

Other insiders filing for Aurinia Pharmaceuticals Inc. (AUPH)

Robertson Stephen P., Chief Legal Officer
Goetz Kathleen, Director
Nova Tina Susan, Director
Bailey Jeffrey Allen, Director
TANG KEVIN, Chief Executive Officer
Hearne Michael S, Chief Financial Officer

How to read Form 4 transaction codes